ACTUNasdaq

ACTUATE THERAPEUTICS, INC.

Alert me on ACTU

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Oct 29 Buy SCHMITT DANIEL M Insider

1 week

−11.9%S&P −4.7%

1 month

Result in14 trading days

3 months

Result in56 trading days

6 months

Result in119 trading days

Jan 7 Sale THOMSON TODD S Insider

1 week

−19.0%S&P +0.1%

1 month

−32.0%S&P +0.2%

3 months

−70.9%S&P −1.1%

6 months

−81.4%S&P +10.1%

Jan 7 Sale Kairos Venture Partners II, L.P. Insider

1 week

−19.0%S&P +0.1%

1 month

−32.0%S&P +0.2%

3 months

−70.9%S&P −1.1%

6 months

−81.4%S&P +10.1%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for ACTU

21 held · newest 521 held · newest 2

Loading the filings.

See all 21 filings for ACTU

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.